Essure: More Dangerous Than Alternatives or Simply a Failure to Communicate Risks?
Business
6355 views
Business
6355 views

Essure: More Dangerous Than Alternatives or Simply a Failure to Communicate Risks?

eyeforpharma - January 11, 2014

By Zuzanna Fiminska Précis: There’s been something of a public backlash against Bayer’s permanent contraception solution, Essure in recent years. By Zuzanna Fiminska Précis: There’s been something of a public backlash…

Business
549 views

Year in Review 2013: Evidence and Market Access

eyeforpharma - January 1, 2014

Précis: 2013 is the year transparency became ‘a thing’, and quite a serious thing at that – particularly when we come to look at market access and the…

Business
511 views

Year in Review 2013: Sales

eyeforpharma - December 31, 2013

Précis: In the second of our ‘year in review’ pieces, we’re looking at the best of our sales content from 2013. It’s been a peculiar year for sales,…